WebJan 31, 2024 · In this protocol, the investigators will perform a pharmacokinetic and local tolerability study of dry powder amikacin using the Cyclops™ in patients with drug susceptible tuberculosis. Objective: primary objective is to investigate the pharmacokinetic properties of dry powder amikacin at different dosages and compare the peak serum … http://www.bcrenal.ca/resource-gallery/Documents/Cyclophosphamide%20Infusion%20Protocol%20For%20GN.pdf
Mycophenolate mofetil versus cyclophosphamide for remission …
WebA long-term follow-up of the CYCLOPS trial revealed a lower risk to relapse in a daily oral group with a cumulative CYC dose of 15.9 g vs an IV group with only 8.2 g. At least 1 … WebJun 26, 2024 · CYCLOPS was an open label multicenter randomized controlled trial (RCT) that evaluated the effect of intermittent intravenous (ivCYC) versus daily oral CYC (poCYC) . The primary outcome was time to remission, defined as the absence of new or worse signs of disease activity on the BVAS and no more than 1 item indicating persistent disease ... porch sleeping beds
Rituximab versus Azathioprine for Maintenance in …
WebCyclophosphamide and glucocorticoids have been the standard therapy for remission induction for nearly four decades. 7,8 This regimen transformed the usual treatment outcome of severe... WebNov 29, 2011 · with the same glucocorticoid protocol (CYCLOPS study (Randomised trial of daily oral versus pulse Cyclophosphamide as therapy for ANCA-associated Systemic Vasculitis published de groot K, harper L et al Ann Int Med 2009)). The study had limited power to detect a difference in relapse. This study describes the WebDec 15, 2024 · Whereas in the CYCLOPS study, patients received a median cyclophosphamide dose of 8.58 g IV and 18.05 g PO [ 4] and our protocol aims to deliver similar cyclophosphamide doses of ~ 10 g to both PO (2 mg/kg for 3 months) and IV (15 mg/kg for 10 cycles over 6 months) groups. sharp ac price in india